As shown in Table 1, we assessed the correlation of AKR1B10 expression with various clinicopathological parameters; and results showed that the expression of AKR1B10 in colorectal cancer tissues was not associated with tumor types, T-pathology, N-pathology, TNM stages, cell differentiation, lymph node metastasis, and regional/distant metastasis. Here, AKR1B10 is linked to colorectal cancer.